 | ||||||
| in | ||||||
| WEB | ||||||
| Zeroing in on Alzheimer In November, another promising drug, solanezumab, also dashed hopes. Because these drugs target either amyloid β (solanezumab) or tau (LMTX), ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
ShareThis
No comments:
Post a Comment